Highly Sensitive Viral RNA-Seq Is a Powerful Tool to Analyze the Viral Transcripts in HTLV-1-Infected Individuals

被引:0
作者
Inada, Yuki
Katsuya, Hiroo
Miyazato, Paola
Tan, Benjy Jek Yang
Iwase, Saori
Kakoki, Misaki
Matsuo, Misaki
Islam, Saiful
Tokunaga, Masahito
Hata, Hiroyuki
Yamano, Yoshihisa
Utsunomiya, Atae
Satou, Yorifumi
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2484
引用
收藏
页数:3
相关论文
共 36 条
[31]   Acute viral load blips in response to subcutaneous interleukin-2 therapy in HIV-1 infected individuals on highly active antiretroviral therapy [J].
Sullivan, AK ;
Imami, N ;
Hardy, GAD ;
Pires, A ;
O'Donavan, B ;
Gotch, FM ;
Gazzard, BG .
AIDS, 2000, 14 :S73-S74
[32]   TEMPERATURE-SENSITIVE MUTANTS OF VESICULAR STOMATITIS-VIRUS - VIRAL-RNA SYNTHESIS IN CELLS INFECTED WITH MUTANTS BELONGING TO COMPLEMENTATION GROUP-1 [J].
CORMACK, DV ;
CHOW, CT ;
HOLLOWAY, AF .
CANADIAN JOURNAL OF MICROBIOLOGY, 1976, 22 (09) :1357-1363
[33]   Intracellular expression of antisense RNA. transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells [J].
Barnor, JS ;
Miyano-Kurosaki, N ;
Yamaguchi, K ;
Sakamoto, A ;
Ishikawa, K ;
Inagaki, Y ;
Yamamoto, N ;
Osei-Kwasi, M ;
Ofori-Adjei, D ;
Takaku, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (02) :544-550
[34]   Evaluation of the Aptima® HIV-1 Quant Dx Assay for HIV-1 RNA Viral Load Detection and Quantitation in Plasma of HIV-1-Infected Individuals: A Comparison With Abbott RealTime HIV-1 Assay [J].
Amendola, Alessandra ;
Pisciotta, Maria ;
Aleo, Loredana ;
Ferraioli, Valeria ;
Angeletti, Claudio ;
Capobianchi, Maria Rosaria .
JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (09) :1535-1544
[35]   CHANGES IN THE VIRAL MESSENGER-RNA EXPRESSION PATTERN CORRELATE WITH A RAPID RATE OF CD4(+) T-CELL NUMBER DECLINE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS [J].
FURTADO, MR ;
KINGSLEY, LA ;
WOLINSKY, SM .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2092-2100
[36]   In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy [J].
Elbeik, T ;
Hoo, BS ;
Campodonico, ME ;
Dileanis, J ;
Fay, FF ;
Marlowe, N ;
Petrauskene, O ;
Chernoff, D ;
Smith, L ;
Ng, VL .
JOURNAL OF HUMAN VIROLOGY, 2001, 4 (06) :317-328